Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital ... More >>

Stock Quote

CSII (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 1.42 (4.89%)
Data as of 11/26/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

More >>
Cardiovascular Systems Receives CE Mark for Stealth 360® Peripheral Orbital Atherectomy System
ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 3, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced that it has received CE (Conformité Européenne) Mark for its Stealth 360º Orbital Atherectomy System (OAS). Stealth 360º is a percutaneous OAS that is indicated to treat patients who suffer from peripheral arterial disease (PAD). “Securing CE Mark for Stealth 360º greatly expands our market opportunity and is an important mil... 
Cardiovascular Systems Reports Fiscal 2015 First-Quarter Financial Results
Conference Call Scheduled for Today, October 29, 2014, at 3:45 PM CT (4:45 PM ET) Revenues grew to $41.4 million, a 39 percent increase over first quarter 2014 Coronary product revenues reached $5.0 million First COAST coronary study patients were enrolled in Japan Liberty 360° enrollment grew to over 400 patients ... 
Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study
International Coronary Trial Underway in United States and Japan Study to Assess Safety and Efficacy of New Coronary Micro Crown to Secure Regulatory Approval in Both Countries ST. PAUL, Minn.--(BUSINESS WIRE)--Oct. 27, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in ... 
Cardiovascular Systems to Webcast Fiscal 2015 First-Quarter Earnings Conference Call Wednesday, October 29
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) ST. PAUL, Minn.--(BUSINESS WIRE)--Oct. 16, 2014-- Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2015 first-quarter conference call on Wednesday, October 29, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss the company’s results for its fiscal first quarter end... 

Upcoming Events

More >>
There are currently no events scheduled.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.